Diabetes
Two Fundus Camera Candidates for DR Screening Show Promise
In a large UK initiative, ultra-widefield imaging demonstrated high sensitivity for referrable cases.
10/10/2024
Fragmented Circadian Rhythm May Increase DR Risk
This potential relationship was tested in part due to the well-documented effect that this bodily process plays in regulating glucose homeostasis.
10/09/2024
Study Identifies OCT-A Parameters to Predict DME Treatment Response
At baseline, patients who experienced good outcomes on ranibizumab therapy tended to have higher vascular densities in the superficial and deep capillary plexuses and smaller FAZ areas.
10/04/2024
Ultra-Widefield FA Imaging Best for Assessing DR Progression Risk
A post hoc analysis found that peripheral lesions beyond conventional ETDRS fields were significantly associated with an increased risk of disease worsening.
09/20/2024
OCT-A Can Detect Early Changes in Kidney Function
Fundus blood flow parameters may aid detection and monitoring of diabetic complications.
09/19/2024
Key Social Determinants Contribute to Inequities in Diabetic Eye Care Access
Study finds rural location, insurance type and preexisting conditions all foster disparities among high-risk groups.
09/17/2024
Study Links Diabetes Subtypes to Accelerated Retinal Thinning
After following patients for four years, researchers identified distinct rates of choroidal and ganglion cell layer loss and are advocating for adjusted screening intervals in these populations.
09/10/2024
Sequence Matters in Combined Treatment Approach for PDR, Study Shows
Patients who received PRP before anti-VEGF were more likely to undergo pars plana vitrectomy for vitreous hemorrhage or RD than those treated in the reverse order.
09/04/2024
Researchers Use Algorithm to Create New Severity Scale for Diabetic Macular Ischemia
It’s based on the distribution of capillary nonperfusion on OCT-A.
08/29/2024
GLP-1 Agonists May Protect Against Glaucoma in Type 2 Diabetes Patients
Compared to metformin, these agents conferred a significantly lower incidence of POAG, ocular hypertension and need for first-line treatments.
08/27/2024
Upcoming Events
October 29, 2024
Redefine Possibilities For Your Patients and Your Practice
Location: Virtual
Presenters: Erick Henderson, OD
Webinar: 9:00pm ET
Sponsored by Bausch + Lomb
November 6, 2024
Showcasing Inflammation and IOP Control
Location: Prime 47
Presenters: Marc Bloomenstein, OD, and Nora Lee Cothran, OD
Time: 7:00pm ET
Sponsored by Bausch + Lomb
November 7, 2024
Racing Ahead: An Engaging Experience with a Trackside Challenge
Location: Commission Row
Presenters: Crystal Brimer, OD, Mile Brujic, OD, and Gina Welsey, OD
Time: 7:30pm ET
Sponsored by Bausch + Lomb
